Sperm-hyaluronan-binding assay: clinical value in conventional IVF under Italian law. | PubFacts
New Sperm Selection Technology for Assisted Reproductive Technology (ART) Cleared by FDA
These priorities may change as more data become available. Hyaluronic Acid Binding Sperm Selection HABSelect is one of the only trials with sufficient power to test the efficacy of a sperm-selection procedure that has shown some promise for improving live birth rate but without conclusive evidence hitherto. Clinical intervention is minimal and applies to in vitro conducted process of sperm selection; similarly, the mechanistic investigation will only make use of the residual sperm left over after the treatment. Reprod Biomed Online ;
The analysis will be by intention to treat. Note accumulated sperm on periphery, considered to be moribund. These products offered the best prospect for assuring continuity of supply, quality control and relative ease of use. It is difficult to assess what impact the PICSI intervention might have on the overall cost of treatment. Forgot your user name or password?
The mean HBA scores ICSI was introduced as a treatment for severe male infertility. Since the intervening embryologist is aware of the arm allocation, there may be a potential for subconscious embryo selection bias, particularly in smaller clinics with fewer staff. There is a known relationship between HA bound sperm and enhanced levels of developmental sperm maturity, including fewer chromosomal aberrations and higher sperm DNA integrity However, depending on the study outcomes, cost-effectiveness modelling alongside an individual patient data IPD meta-analysis may be considered. In order to promote better understanding of our results we briefly explain some of the complicated events involved in the fertilization process. The Trial Steering Committee will agree a publication plan and be consulted prior to release or otherwise publish any study data.